NCT05312073COMPLETEDanonymous

Study of In Vivo and in Vitro Transcriptomic and Proteomic Signatures in Unhereditary Ichtyosis

Sponsor

Source record

Assistance Publique - Hôpitaux de Paris

Phase

Source record

Modality

AI-normalized

protein therapy

Target

AI-normalized

Biological samples, Skin biopsy

Indication / condition

AI-normalized

Autosomal Recessive Congenital Ichthyosis

Intervention

Source record

Biological samples, Skin biopsy

Related intelligence directories

Indication directory: Autosomal Recessive Congenital Ichthyosis Modality directory: protein therapy Target directory: Biological samples

Source & freshness

Source record

NCT ID

NCT05312073

Original source

ClinicalTrials.gov

Source last updated

Detailed source ingestion pending.

Ingested at

Jul 25, 2026

Internal sync

Jul 25, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT05312073

Title

Study of In Vivo and in Vitro Transcriptomic and Proteomic Signatures in Unhereditary Ichtyosis

Sponsor

Assistance Publique - Hôpitaux de Paris

Status

COMPLETED

Phase

Condition raw

Autosomal Recessive Congenital Ichthyosis, Epidermolytic Ichthyosis

Condition normalized

Autosomal Recessive Congenital Ichthyosis, Epidermolytic Ichthyosis

Modality raw

protein therapy

Modality normalized

protein therapy

Target raw

Biological samples, Skin biopsy

Target normalized

Biological samples, Skin biopsy

Interventions

Biological samples, Skin biopsy

Public preview

Source record

Study of In Vivo and in Vitro Transcriptomic and Proteomic Signatures in Unhereditary Ichtyosis is a NA clinical asset sponsored by Assistance Publique - Hôpitaux de Paris in Autosomal Recessive Congenital Ichthyosis, Epidermolytic Ichthyosis. SEO and diligence focus: Biological samples, Skin biopsy, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Study of In Vivo and in Vitro Transcriptomic and Proteomic Signatures in Unhereditary Ichtyosis

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jul 28, 2026

Report code

NCT05312073-Jul 28, 2026

NCT ID

NCT05312073

Status

COMPLETED

Phase

Sponsor

Assistance Publique - Hôpitaux de Paris

Executive brief

Investment-Ready Snapshot

Study of In Vivo and in Vitro Transcriptomic and Proteomic Signatures in Unhereditary Ichtyosis is a NA clinical asset sponsored by Assistance Publique

Hôpitaux de Paris in Autosomal Recessive Congenital Ichthyosis, Epidermolytic Ichthyosis. SEO and diligence focus: Biological samples, Skin biopsy, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedDetailed source ingestion pending.

Internal syncJul 25, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT05312073

Indication

Autosomal Recessive Congenital Ichthyosis

Modality

protein therapy

Target

Biological samples, Skin biopsy

Intervention

Biological samples, Skin biopsy

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.